Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-UTR Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

Technology
E-089-2002
Patent ID
E-089-2002-1-US-51
Country
US
Application Type
DIV
Patent Status
Expired
Patent Number
10837003
Publication Number
US-2018-0010099-A1
Application Number
15/710,672
IC
NIAID
Date Filed
Date Issued
Patent PDF
https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/10837003
Related Technologies
TAB-671     Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in the 3'-UTR of Dengue Types 1, 2, 3, and 4